10,750 Shares in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Bought by M Holdings Securities Inc.

M Holdings Securities Inc. bought a new position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIXGet Rating) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 10,750 shares of the specialty pharmaceutical company’s stock, valued at approximately $30,000. M Holdings Securities Inc. owned about 0.07% of Cumberland Pharmaceuticals as of its most recent SEC filing.

Separately, Acadian Asset Management LLC grew its holdings in shares of Cumberland Pharmaceuticals by 27.8% during the first quarter. Acadian Asset Management LLC now owns 188,243 shares of the specialty pharmaceutical company’s stock valued at $529,000 after buying an additional 40,949 shares in the last quarter. 18.48% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on Cumberland Pharmaceuticals in a research report on Sunday. They set a “hold” rating for the company.

Cumberland Pharmaceuticals Trading Down 1.1 %

Shares of Cumberland Pharmaceuticals stock opened at $2.60 on Tuesday. Cumberland Pharmaceuticals Inc. has a 1 year low of $1.89 and a 1 year high of $7.51. The company has a current ratio of 1.80, a quick ratio of 1.42 and a debt-to-equity ratio of 0.48. The company’s fifty day simple moving average is $2.35 and its 200-day simple moving average is $2.37. The company has a market cap of $38.12 million, a price-to-earnings ratio of -5.10 and a beta of 0.32.

About Cumberland Pharmaceuticals

(Get Rating)

Cumberland Pharmaceuticals Inc, a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of chronic and acute constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.

See Also

Want to see what other hedge funds are holding CPIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cumberland Pharmaceuticals Inc. (NASDAQ:CPIXGet Rating).

Institutional Ownership by Quarter for Cumberland Pharmaceuticals (NASDAQ:CPIX)

Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.